Diagonal Bio
0.028 SEK -0.36%1 investor is following this company
Diagonal Bio operates in the biotechnology industry. The company is developing a platform under the name Panviral to detect and diagnose small sections of pathogen genomes, such as viruses, bacteria, and fungi. In addition to the main business, service and associated ancillary services are also offered. The largest operations take place in Sweden with headquarter in Lund.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
DIABIO
Daily low / high price
0.027 / 0.028
SEK
Market cap
11.06M SEK
Turnover
5.74K SEK
Volume
207K
Financial calendar
Interim report
2024-08-22
Interim report
2024-10-31
Annual report
2025-02-25
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Nordnet Pensionsförsäkring AB | 6.5 % | 6.5 % |
Avanza Pension | 5.7 % | 5.7 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Bulletin from the Annual General Meeting on 11 June 2024 in Diagonal Bio AB
Kommuniké från årsstämma den 11 juni 2024 i Diagonal Bio AB
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools